Stay updated with breaking news from Deliverytm peddtm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TriSalus Life Sciences Inc., , today announced the closing of a debt financing facility for up to $50 million with OrbiMed, a healthcare investment firm. The capital is expected to provide financial flexibility to support the execution of strategic. ....
Haystack Oncology, developer of Haystack MRDtm, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinoma lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.